BioCentury | Dec 8, 2014
Company News

LipoScience, LabCorp deal

...diagnostic company LipoScience for $5.25 per share in cash, or about $85.4 million. LabCorp said LipoScience’s...
...personalize management of heart disease. At Sept. 30, LipoScience reported $29.6 million in nine-month revenue. LipoScience Inc....
BioCentury | Jan 6, 2014
Finance

2014 Financial Markets Preview: Hoping the pause is brief

...water at year end (see "IPO Performance," A7) . Among the three in the red, LipoScience Inc....
...Calif. Intarcia Therapeutics Inc. , Boston, Mass. KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO), South San Francisco, Calif. LipoScience Inc....
...Chg from lockup Adj lockup chg (B) Pre-lockup vol % (C) Post-lockup vol % (C) LipoScience Inc....
BioCentury | Oct 28, 2013
Finance

Hoping to give thanks

...$M Chg from lockup Adj lockup chg (B) Chg from IPO Adj IPO chg (B) LipoScience Inc....
BioCentury | Sep 16, 2013
Company News

LipoScience management update

LipoScience Inc. (NASDAQ:LPDX), Raleigh, N.C. Business: Diagnostic Hired: William Cromwell as CMO, founder of the Lipoprotein and Metabolic Disorders Institute (LMDI) WIR Staff Diagnostic...
BioCentury | Aug 12, 2013
Finance

A disciplined crowd

...or those that limped out the door in the first place. After initially trading up, LipoScience Inc....
...It closed the day off $1.96 (23%) to $6.50. Gordon noted that diagnostic companies like LipoScience...
...Md. Iroko Pharmaceuticals LLC , Philadelphia, Pa. KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO), South San Francisco, Calif. LipoScience Inc....
BioCentury | Jul 1, 2013
Finance

3Q Financial Markets Preview: Window watching

...NASDAQ:KBIO) 1/31/13 $70.0 $193.0 $136.8 -29% Stemline Therapeutics Inc. (NASDAQ:STML) 1/28/13 $38.2 $74.6 $296.4 297% LipoScience Inc....
BioCentury | Jun 17, 2013
Finance

Level-headed enthusiasm

...NASDAQ:KBIO) 1/31/13 $70.0 $193.0 $121.4 -37% Stemline Therapeutics Inc. (NASDAQ:STML) 1/28/13 $38.2 $74.6 $249.8 235% LipoScience Inc....
BioCentury | Apr 1, 2013
Finance

2Q Financial Markets Preview: Looking for 'growthier'

...NASDAQ:KBIO) 1/31/13 $70.0 $193.0 $144.8 -25% Stemline Therapeutics Inc. (NASDAQ:STML) 1/28/13 $38.2 $74.6 $85.1 14% LipoScience Inc....
BioCentury | Mar 25, 2013
Finance

Done with biotech

...transplant company APT Pharmaceuticals Inc. , chemistry platform company Concert Pharmaceuticals Inc. , diagnostic play LipoScience Inc....
BioCentury | Feb 4, 2013
Financial News

LipoScience financial update

...to $51.8 million. The company, which closed Friday at $10.68, has 14.6 million shares outstanding. LipoScience Inc....
Items per page:
1 - 10 of 32
BioCentury | Dec 8, 2014
Company News

LipoScience, LabCorp deal

...diagnostic company LipoScience for $5.25 per share in cash, or about $85.4 million. LabCorp said LipoScience’s...
...personalize management of heart disease. At Sept. 30, LipoScience reported $29.6 million in nine-month revenue. LipoScience Inc....
BioCentury | Jan 6, 2014
Finance

2014 Financial Markets Preview: Hoping the pause is brief

...water at year end (see "IPO Performance," A7) . Among the three in the red, LipoScience Inc....
...Calif. Intarcia Therapeutics Inc. , Boston, Mass. KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO), South San Francisco, Calif. LipoScience Inc....
...Chg from lockup Adj lockup chg (B) Pre-lockup vol % (C) Post-lockup vol % (C) LipoScience Inc....
BioCentury | Oct 28, 2013
Finance

Hoping to give thanks

...$M Chg from lockup Adj lockup chg (B) Chg from IPO Adj IPO chg (B) LipoScience Inc....
BioCentury | Sep 16, 2013
Company News

LipoScience management update

LipoScience Inc. (NASDAQ:LPDX), Raleigh, N.C. Business: Diagnostic Hired: William Cromwell as CMO, founder of the Lipoprotein and Metabolic Disorders Institute (LMDI) WIR Staff Diagnostic...
BioCentury | Aug 12, 2013
Finance

A disciplined crowd

...or those that limped out the door in the first place. After initially trading up, LipoScience Inc....
...It closed the day off $1.96 (23%) to $6.50. Gordon noted that diagnostic companies like LipoScience...
...Md. Iroko Pharmaceuticals LLC , Philadelphia, Pa. KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO), South San Francisco, Calif. LipoScience Inc....
BioCentury | Jul 1, 2013
Finance

3Q Financial Markets Preview: Window watching

...NASDAQ:KBIO) 1/31/13 $70.0 $193.0 $136.8 -29% Stemline Therapeutics Inc. (NASDAQ:STML) 1/28/13 $38.2 $74.6 $296.4 297% LipoScience Inc....
BioCentury | Jun 17, 2013
Finance

Level-headed enthusiasm

...NASDAQ:KBIO) 1/31/13 $70.0 $193.0 $121.4 -37% Stemline Therapeutics Inc. (NASDAQ:STML) 1/28/13 $38.2 $74.6 $249.8 235% LipoScience Inc....
BioCentury | Apr 1, 2013
Finance

2Q Financial Markets Preview: Looking for 'growthier'

...NASDAQ:KBIO) 1/31/13 $70.0 $193.0 $144.8 -25% Stemline Therapeutics Inc. (NASDAQ:STML) 1/28/13 $38.2 $74.6 $85.1 14% LipoScience Inc....
BioCentury | Mar 25, 2013
Finance

Done with biotech

...transplant company APT Pharmaceuticals Inc. , chemistry platform company Concert Pharmaceuticals Inc. , diagnostic play LipoScience Inc....
BioCentury | Feb 4, 2013
Financial News

LipoScience financial update

...to $51.8 million. The company, which closed Friday at $10.68, has 14.6 million shares outstanding. LipoScience Inc....
Items per page:
1 - 10 of 32